Insufficient scRNA-seq data for expression of PM20D1 at single-cell level.
Insufficient scRNA-seq data for expression of PM20D1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 99% | 4863.32 | 326 / 328 | 43% | 25.68 | 76 / 178 |
bladder | 76% | 180.43 | 16 / 21 | 40% | 59.05 | 201 / 504 |
kidney | 84% | 186.94 | 75 / 89 | 23% | 0.67 | 204 / 901 |
ureter | 0% | 0 | 0 / 0 | 100% | 56.44 | 1 / 1 |
thymus | 81% | 41.46 | 532 / 653 | 19% | 0.41 | 112 / 605 |
ovary | 80% | 66.96 | 144 / 180 | 13% | 0.45 | 54 / 430 |
stomach | 81% | 317.87 | 292 / 359 | 9% | 0.21 | 25 / 286 |
adrenal gland | 39% | 12.43 | 101 / 258 | 48% | 2.96 | 111 / 230 |
spleen | 84% | 88.97 | 202 / 241 | 0% | 0 | 0 / 0 |
breast | 80% | 38.97 | 365 / 459 | 4% | 0.14 | 44 / 1118 |
lung | 76% | 27.71 | 440 / 578 | 7% | 0.19 | 81 / 1155 |
adipose | 80% | 45.08 | 963 / 1204 | 0% | 0 | 0 / 0 |
heart | 77% | 57.20 | 661 / 861 | 0% | 0 | 0 / 0 |
skin | 66% | 1776.47 | 1189 / 1809 | 4% | 1.98 | 20 / 472 |
uterus | 61% | 21.12 | 103 / 170 | 7% | 5.27 | 32 / 459 |
intestine | 59% | 26.33 | 573 / 966 | 7% | 0.29 | 36 / 527 |
esophagus | 45% | 12.51 | 644 / 1445 | 15% | 0.26 | 28 / 183 |
blood vessel | 57% | 23.55 | 759 / 1335 | 0% | 0 | 0 / 0 |
prostate | 48% | 13.42 | 117 / 245 | 0% | 0.06 | 2 / 502 |
lymph node | 0% | 0 | 0 / 0 | 41% | 0.93 | 12 / 29 |
peripheral blood | 39% | 13.29 | 366 / 929 | 0% | 0 | 0 / 0 |
brain | 31% | 8.10 | 819 / 2642 | 2% | 0.16 | 16 / 705 |
liver | 18% | 4.63 | 41 / 226 | 2% | 0.20 | 10 / 406 |
muscle | 15% | 3.24 | 120 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
GO_0044255 | Biological process | cellular lipid metabolic process |
GO_0097009 | Biological process | energy homeostasis |
GO_0006520 | Biological process | amino acid metabolic process |
GO_0043605 | Biological process | amide catabolic process |
GO_0006508 | Biological process | proteolysis |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_1990845 | Biological process | adaptive thermogenesis |
GO_0043604 | Biological process | amide biosynthetic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0016811 | Molecular function | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides |
GO_0008233 | Molecular function | peptidase activity |
GO_0016829 | Molecular function | lyase activity |
GO_0004046 | Molecular function | aminoacylase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | PM20D1 |
Protein name | N-fatty-acyl-amino acid synthase/hydrolase PM20D1 (EC 3.5.1.114) (EC 3.5.1.14) (Peptidase M20 domain-containing protein 1) |
Synonyms | |
Description | FUNCTION: Secreted enzyme that regulates the endogenous N-fatty acyl amino acid (NAAs) tissue and circulating levels by functioning as a bidirectional NAA synthase/hydrolase . It condenses free fatty acids and free amino acids to generate NAAs and bidirectionally catalyzes the reverse hydrolysis reaction . Some of these NAAs stimulate oxidative metabolism via mitochondrial uncoupling, increasing energy expenditure in a UPC1-independent manner. Thereby, this secreted protein may indirectly regulate whole body energy expenditure. PM20D1 circulates in tight association with both low- and high-density (LDL and HDL,respectively) lipoprotein particles (By similarity). . |
Accessions | Q6GTS8 ENST00000367136.5 [Q6GTS8-1] |